Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

NCT00094172

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Keck School of Medicine Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Yale MS Research Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Completed

Pulse ACTH vs. MP for MS

NCT01049451

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • USC MS Center Los Angeles, California, United States
View Trial Details
Completed

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

NCT02125604

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Augsburg, Germany
  • Research Site Bamburg, Germany
  • Research Site Bayreuth, Germany
  • Research Site Berlin, Germany
View all 19 locations
View Trial Details
Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

NCT00548405

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • Barrow Neurological Institute, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Hope Research Institute Phoenix, Arizona, United States
  • Mayo Clinic Arizona, Department of Neurology Scottsdale, Arizona, United States
View all 191 locations
View Trial Details
Completed

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

NCT00573443

Conditions
Amyotrophic Lateral Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Neuromuscular Research Center Scottsdale, Arizona, United States
  • South Coast Clinical Trials Anaheim, California, United States
  • UCI Medical Center Irvine, California, United States
View all 62 locations
View Trial Details

Related conditions